Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
about
Passive immunity in prevention and treatment of infectious diseasesUse of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role.Bronchiolitis.Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatmentIntranasal antibody prophylaxis for protection against viral disease.Active and passive immunisation against respiratory syncytial virus.RSV infection in infants and young children. What's new in diagnosis, treatment, and prevention?Respiratory syncytial virus vaccinesUse of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.An update on respiratory syncytial virus antiviral agents.Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing.Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis.Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention.Respiratory syncytial virus: current and emerging treatment optionsPalivizumab and respiratory syncytial virus immune globulin intravenous for the prophylaxis of respiratory syncytial virus infection in high risk infants.Comparison of corticosteroids for treatment of respiratory syncytial virus bronchiolitis and pneumonia in cotton rats.Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection.A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways.Treatment with novel RSV Ig RI-002 controls viral replication and reduces pulmonary damage in immunocompromised Sigmodon hispidus.The effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis.Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.The therapeutic potential of monoclonal antibodies against respiratory syncytial virus.Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice.Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial.Severity of illness models for respiratory syncytial virus-associated hospitalization.Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.
P2860
Q24550699-D240A855-907C-4BEB-B303-01400FBEB6FEQ30145641-D8618014-B0E3-4477-A7E7-08FCAE77673EQ33446856-A717959D-61EE-4022-B090-B74AD737EC10Q33588916-34566E73-C976-4A63-99DD-C91C69D60183Q33683058-84610D52-1D81-42D1-90DF-6E06C4717712Q33782438-2A69BAA1-B383-4EB1-BC59-BE445C28EFBCQ33802570-EEB74C5B-D9DA-4BA3-A6A3-CC0D4FF96279Q33975330-74491EE6-8027-4512-A8D7-FB1A1EAA8C00Q33999369-2D576A65-1314-45F4-9428-0691DD9B5336Q34141078-30F6D939-23E0-4552-82C9-4716A402D389Q34740851-13381A3E-15EC-48DA-A606-C5DCE20CC0D4Q35871250-7AD75BD5-5271-48B9-9F87-575613A9E672Q36322131-4C196797-6E23-42F7-B358-CCAE0F574E77Q37841264-F9521947-2480-4BC6-AB5C-8E01128349DAQ37841269-A0ABD68C-9760-463E-A433-8F15497A5492Q38210541-FB1A3FBE-EB75-4DB6-AC25-0344F77A7115Q39244621-D18C42E2-D8D7-40BA-BFB6-1623AC5DBCA0Q39652266-E130D888-689F-4EF7-876A-B398821268C0Q40039908-C5C59CEC-27A5-479C-8E78-38C418D694A8Q40894883-289DED0D-0C09-468B-AA60-96FCB8DE113FQ41001772-68DF8D9A-C8C9-41F2-B9DF-87B701DECC24Q43660401-5ADC7297-1FBF-435C-BFEF-21ECF54BD0A9Q44923546-7C5398A7-8F40-4F19-9037-1C0C095E7539Q45439981-0D2774CC-9B3B-4989-AFA3-73070D8CA0A3Q45740485-71C5FAAF-83CB-4B72-B973-9295A73E5CCFQ45744471-CE89BCB3-A34B-455D-B9B6-7D265AACE787Q45747450-35F25146-AEFF-4699-B657-72BC2D1AEAC1Q45750249-414968C9-6E54-4815-A71C-1CBC8DA829E5Q54209804-93216B96-2FA6-4CFD-89A6-2ADEC1F4DFA6
P2860
Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Respiratory syncytial virus (R ...... s Immune Globulin Study Group.
@en
type
label
Respiratory syncytial virus (R ...... s Immune Globulin Study Group.
@en
prefLabel
Respiratory syncytial virus (R ...... s Immune Globulin Study Group.
@en
P2093
P356
P1433
P1476
Respiratory syncytial virus (R ...... s Immune Globulin Study Group.
@en
P2093
Groothuis JR
Hemming VG
Meissner HC
Robertsen C
Rodriguez WJ
P304
P356
10.1542/PEDS.99.3.454
P407
P577
1997-03-01T00:00:00Z